Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor-Reference-Cited by-同舟云学术

Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor

Published:2010-12 Issue:8 Volume:12 Page:1044-1055
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Sutlu Tolga,Stellan Birgitta,Gilljam Mari,Quezada Hernan Concha,Nahi Hareth,Gahrton Gösta,Alici Evren

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference30 articles.

1. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes;Grimm;J Exp Med,1982

2. Lymphokine-activated killer cells: a new ap-proach to immunotherapy of cancer;Rosenberg;J Natl Cancer Inst,1985

3. Natural killer cell-based immunotherapy in cancer: current insights and future prospects;Sutlu;J Intern Med,2009

4. A new method for in vitro expansion of cytotoxic human CD3−CD56+ natural killer cells;Carlens;Human Immunol,2001

5. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy;Guven;Leukemia,2003

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy;Journal of Translational Medicine;2024-08-05

2. A review and statistical analysis to identify and describe relationships between CQAs and CPPs of natural killer cell expansion processes;Cytotherapy;2024-06

3. Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy;Cells;2024-03-05

4. Enhanced NK cell proliferation by stress-induced feeder cells;2024-02-12

5. PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer;Experimental & Molecular Medicine;2024-01-10